Pharmacological Activities of Glial Cell Line-Derived Neurotrophic Factor (GDNF): Preclinical Development and Application to the Treatment of Parkinson's Disease

This publication has 50 references indexed in Scilit:

• GDNF Selectively Protects Dopamine Neurons over Serotonin Neurons Against the Neurotoxic Effects of Methamphetamine
  Journal of Neuroscience, 1996
• 6-Hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat
  Experimental Brain Research, 1996
• Glial cell line-derived neurotrophic factor reverses motor impairment in 16–17 month old rats
  Neuroscience Letters, 1996
• Functional recovery in parkinsonian monkeys treated with GDNF
  Nature, 1996
• GDNF mRNA expression in normal postnatal development, aging, and in weaver mutant mice
  Neurobiology of Aging, 1995
• Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys
  Journal of Comparative Neurology, 1995
• GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo
  Neuron, 1995
• Glial cell line‐derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons
  Journal of Comparative Neurology, 1995
• Evidence that neuropeptide Y and dopamine in the perifornical hypothalamus interact antagonistically in the control of food intake
  Brain Research, 1993
• Midbrain Dopaminergic Cell Loss in Parkinson's Disease and MPTP‐Induced Parkinsonism: Sparing of Calbindin‐D_25k—Containing Cells^a
  Annals of the New York Academy of Sciences, 1992